CN101208355A - 真菌和/或原生生物感染的治疗 - Google Patents

真菌和/或原生生物感染的治疗 Download PDF

Info

Publication number
CN101208355A
CN101208355A CNA200680023372XA CN200680023372A CN101208355A CN 101208355 A CN101208355 A CN 101208355A CN A200680023372X A CNA200680023372X A CN A200680023372XA CN 200680023372 A CN200680023372 A CN 200680023372A CN 101208355 A CN101208355 A CN 101208355A
Authority
CN
China
Prior art keywords
polypeptide
seq
application
polypeptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200680023372XA
Other languages
English (en)
Chinese (zh)
Inventor
柯蒂斯·多布森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ai2 Ltd
Original Assignee
Ai2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ai2 Ltd filed Critical Ai2 Ltd
Publication of CN101208355A publication Critical patent/CN101208355A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A01N37/30—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the groups —CO—N< and, both being directly attached by their carbon atoms to the same carbon skeleton, e.g. H2N—NH—CO—C6H4—COOCH3; Thio-analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CNA200680023372XA 2005-06-28 2006-06-26 真菌和/或原生生物感染的治疗 Pending CN101208355A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0513096.8 2005-06-28
GBGB0513096.8A GB0513096D0 (en) 2005-06-28 2005-06-28 Treatment of microbial infections

Publications (1)

Publication Number Publication Date
CN101208355A true CN101208355A (zh) 2008-06-25

Family

ID=34856225

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200680023372XA Pending CN101208355A (zh) 2005-06-28 2006-06-26 真菌和/或原生生物感染的治疗

Country Status (14)

Country Link
US (3) US20080207508A1 (https=)
EP (1) EP1896502B1 (https=)
JP (1) JP2008546831A (https=)
KR (2) KR20080030060A (https=)
CN (1) CN101208355A (https=)
AU (1) AU2006263600B2 (https=)
BR (1) BRPI0612103A2 (https=)
CA (1) CA2610720A1 (https=)
DK (1) DK1896502T3 (https=)
ES (1) ES2427171T3 (https=)
GB (1) GB0513096D0 (https=)
PL (1) PL1896502T3 (https=)
RU (1) RU2008102928A (https=)
WO (1) WO2007000584A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105749250A (zh) * 2016-03-14 2016-07-13 吉林大学 林蛙抗菌肽在治疗灰指甲的药物制备中的用途

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
ITTO20080894A1 (it) * 2008-12-02 2010-06-03 Bioindustry Park Del Canavese S P A Uso dell'aptoglobina, peptidi leganti l'aptoglobina, polimeri contenenti gli stessi e loro uso
JP5463515B2 (ja) * 2009-02-12 2014-04-09 独立行政法人農業生物資源研究所 抗微生物ペプチドを固定化した素材
EP2892913A4 (en) * 2012-09-07 2017-01-18 Agency For Science, Technology And Research Peptides and their uses
WO2014053879A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
MX387665B (es) 2014-12-24 2025-03-18 Aadigen Llc Péptidos, complejos, moléculas de carga y nanopartículas que contienen los mismos.
SG11201708815UA (en) * 2015-05-29 2017-12-28 Hexima Ltd A method of in vivo treatment
KR102677968B1 (ko) * 2021-12-20 2024-06-26 세메스 주식회사 버퍼 유닛 및 이를 포함하는 기판 처리 장치
CN116376795B (zh) * 2023-03-29 2023-11-07 中国水产科学研究院珠江水产研究所 一种表达hsp70的重组乳酸菌及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294605A (en) 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
GB9705831D0 (en) 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
KR100314721B1 (ko) 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
AU2997099A (en) 1998-03-11 1999-09-27 Duke University Methods of suppressing microglial activation
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
GB0103424D0 (en) 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US20040014955A1 (en) 2001-12-17 2004-01-22 Carlos Zamudio Identification of essential genes of cryptococcus neoformans and methods of use
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
US20050208078A1 (en) * 2003-11-20 2005-09-22 Hoffman Stephen L Methods for the prevention of malaria
AU2004283078A1 (en) 2003-10-01 2005-05-06 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
ITFI20030324A1 (it) 2003-12-22 2005-06-23 Celbo S R L Gruppo guidafilo per distribuire ed avvolgere filati per formare bobine.
GB0329958D0 (en) * 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105749250A (zh) * 2016-03-14 2016-07-13 吉林大学 林蛙抗菌肽在治疗灰指甲的药物制备中的用途

Also Published As

Publication number Publication date
WO2007000584A1 (en) 2007-01-04
JP2008546831A (ja) 2008-12-25
BRPI0612103A2 (pt) 2011-12-20
EP1896502A1 (en) 2008-03-12
DK1896502T3 (da) 2013-10-14
RU2008102928A (ru) 2009-08-10
EP1896502B1 (en) 2013-07-31
KR20080030060A (ko) 2008-04-03
US20080207508A1 (en) 2008-08-28
AU2006263600B2 (en) 2012-09-20
US20150190462A1 (en) 2015-07-09
ES2427171T3 (es) 2013-10-29
KR20110099069A (ko) 2011-09-05
US20120258907A1 (en) 2012-10-11
WO2007000584A8 (en) 2013-01-24
CA2610720A1 (en) 2007-01-04
PL1896502T3 (pl) 2013-12-31
AU2006263600A1 (en) 2007-01-04
GB0513096D0 (en) 2005-08-03
HK1113162A1 (en) 2008-10-24
US8916516B2 (en) 2014-12-23

Similar Documents

Publication Publication Date Title
US8916516B2 (en) Treatment of fungal and/or protist infections
Ladram et al. Antimicrobial peptides from frog skin: biodiversity and therapeutic promises
CA2372821C (en) Antimicrobial theta defensins and methods of using same
RU2472805C2 (ru) Антибиотические пептиды
JP5335241B2 (ja) 抗微生物ヘキサペプチド
AU683725B2 (en) Broad spectrum antimicrobial compounds and methods of use
US8686113B2 (en) Antibiotic peptides
KR100891157B1 (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
CN105555290A (zh) 抗微生物肽
Hagemann et al. Therapeutic potential of antimicrobial peptides against pathogenic protozoa
US20110288007A1 (en) Biocidal fusion peptide comprising ll-37
WO1999058141A1 (en) Indolicidin analogs and methods of using same
Falanga et al. Emerging therapeutic agents on the basis of naturally occurring antimicrobial peptides
US7745390B2 (en) Antimicrobial peptides
HK1113162B (en) Treatment of fungal and/or protist infections
CN107849103A (zh) 新抗微生物肽、它们的变体和用途
WO2015099535A1 (en) Thrombocidin-derived antimicrobial peptides
Park et al. Isolation and functional analysis of a 24‐residue linear α‐helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera)
US20060241026A1 (en) Novel cyclic peptides and use thereof as anti-microbial agents
Prusty Peptides and polypeptides
CN107949568A (zh) 新抗微生物肽、它们的变体和用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20080625